Trial NCT00112905

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02975
Secondary IDs: E1804 NCI-2012-02975 U10CA021115

Last trial update was posted on 2014-05-30

MeSH Interventions

Sorafenib

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell Kidney Neoplasms Recurrence Ureteral Neoplasms Urethral Neoplasms Urinary Bladder Neoplasms

Other Conditions

Adenocarcinoma of the Bladder Distal Urethral Cancer Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Proximal Urethral Cancer Recurrent Bladder Cancer Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Recurrent Urethral Cancer Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Squamous Cell Carcinoma of the Bladder Stage III Bladder Cancer Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder Urethral Cancer Associated With Invasive Bladder Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID